NCT00293046已完成3 期
A Randomised, Parallel-Group, Open, Controlled Phase III Trial Assessing the Treatment Compliance With GRAZAX® in Subjects With Seasonal Grass Pollen Induced Rhinoconjunctivitis
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 500
- 试验地点
- 2
- 主要终点
- Assessment of treatment compliance by recording of drug accountability
研究概览
简要总结
This trial is performed to assess whether the Grazax® treatment compliance can be improved by use of a compliance device (Memozax®).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Grass pollen induced rhinoconjunctivitis
- •Males and females, 18-65 years of age
- •Positive skin prick test
排除标准
- •Previous treatment with grass pollen allergen
结局指标
主要结局
Assessment of treatment compliance by recording of drug accountability
次要结局
- Recording of adverse events
研究者
研究点 (2)
Loading locations...
相似试验
已完成
3 期
A Phase III Trial Assessing the Pharmacodynamic Effect and the Tolerability of Grazax TreatmentGrass Pollen AllergyNCT00773240ALK-Abelló A/S276
已完成
4 期
Tolerability of Grazax in Patients With Hayfever in Real Life SettingsAllergic RhinoconjunctivitisNCT01433510ALK-Abelló A/S628
已完成
3 期
Efficacy and Safety of Grazax in ChildrenAllergyNCT00408616ALK-Abelló A/S253
已完成
3 期
A Trial of Grazax in Subjects With HayfeverAllergyNCT00421655ALK-Abelló A/S329
已完成
1 期
Tolerability of Grazax-R in ChildrenAllergyNCT00298701ALK-Abelló A/S50